In Response to Outcomes by ALK Status (Immunohistochemistry or Fluorescence In Situ Hybridization) in ALEX. Mok T. J Thorac Oncol 2022;17:e62-e63.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mok T. In Response to Outcomes by ALK Status (Immunohistochemistry or Fluorescence In Situ Hybridization) in ALEX. J Thorac Oncol 2022;17:e62-e63.
PMID: 35623682